Skip to content

Japan-multimodal intervention Trial for prevention of dementia (J-MINT) in Kanagawa

Japan-multimodal intervention Trial for prevention of dementia (J-MINT) in Kanagawa - J-MINT PRIME Kanagawa study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041887
Enrollment
240
Registered
2020-09-28
Start date
2020-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Older adults with lifestyle-related disease.

Interventions

Multidomain intervention including the management of lifestyle-related disease, exercise, nutritional guidance, and cognitive training. Diabetes, hypertension, and dyslipidemia will be treated accordi
will be provided by using iPad. Usual care. Providing documents regarding lifestyle and behaviors for the prevention of dementia.

Sponsors

Yokohama City University
Lead Sponsor
National Center for Geriatrics and Gerontology
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects who 1)live in Yokohama Wakabadai housing complex. 2)aged 65-85 at the time of enroll. 3)are treating lifestyle-related disease or with the risk of lifestyle-related disease. 4)have provided a written informed consent on this study by subjects.

Exclusion criteria

Exclusion criteria: Subjects who 1)have severe functional impairement. 2)are diagnosed with dementia. 3)have MMSE score of less than 24. 4)are unable to speak in Japanese. 5)are unable to perform cognitive tests. 6)have a care-needs certification in the long-term care insurance system. 7)are deemed ineligible for enrollment by the renponsible researcher or co-researcher.

Design outcomes

Primary

MeasureTime frame
Change in a composite score of cognitive function from baseline to a 18-month follow up.

Secondary

MeasureTime frame
1)Changes in a composite score of cognitive function from baseline to a 6/12-month follow up. 2)Changes in scores of each cognitive test from baseline to a 6/12/18-month follow up. 3)Changes in ADL scores from baseline to a 6/18-month follow up. 4)Changes in the status of frailty from baseline to a 6/18-month follow up. 5)Changes in the number of medications. 6)Incident dementia.

Countries

Japan

Contacts

Public ContactToshinari Odawara

Yokohama City University Health Management Center

odawara@yokohama-cu.ac.jp045-787-2144

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026